The Relative Strength (RS) Rating for Steris entered a new percentile Tuesday, with an increase from 74 to 81.
IBD's proprietary rating tracks price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the market's biggest winners often have an 80 or higher RS Rating in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Steris is building a with a 248.24 entry. See if it can clear the breakout price in volume at least 40% higher than normal.
Steris posted 11% EPS growth last quarter, while sales growth came in at 6%.
Steris earns the No. 6 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical, iRadimed and Masimo are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
